Bevacizumab (Avastin) treatment for severe pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia

Mei-Zahav, M; Rosengarten, D; Issachar, A; Blau, H; Stemmer, S; Kramer, M

ANGIOGENESIS, 2018; 21 (1): 118